Week in review: Diabetic retinopathy and glaucoma, ocular biomarkers for Alzheimer’s, preservative-free latanoprost
- Posted on: Dec 16 2022
- Leave a response
Diabetic retinopathy, glaucoma, and ocular hypertension may be linked, ocular biomarkers may predict Alzheimer’s disease, ARVO announces its Advocacy Award winners, and the first preservative-free formulation of latanoprost wins FDA approval.
Source: AAO
Posted in: Uncategorized
